Healthcare Industry Reports

Reports > Healthcare > Selected Report

Global Oncolytic Virus Therapy Market Report for Period 2018 till 2024

Single User: $2195
Multiple User: $3195
Enterprise User: $4195


Report Summary:

Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasnt until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.

Scope of the Report:
This report focuses on the Oncolytic Virus Therapy in global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.
Market Segment by Manufacturers, this report covers
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Market Segment by Applications, can be divided into
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

There are 15 Chapters to deeply display the global Oncolytic Virus Therapy market.

Chapter 1, to describe Oncolytic Virus Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Oncolytic Virus Therapy, with sales, revenue, and price of Oncolytic Virus Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncolytic Virus Therapy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Oncolytic Virus Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Oncolytic Virus Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 Oncolytic Virus Therapy Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.3.1 Melanoma
1.3.2 Prostate Cancer
1.3.3 Breast Cancer
1.3.4 Ovarian Cancer
1.3.5 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market Status and Outlook (2013-2023)
1.4.1.2 Canada Market Status and Outlook (2013-2023)
1.4.1.3 Mexico Market Status and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market Status and Outlook (2013-2023)
1.4.2.2 France Market Status and Outlook (2013-2023)
1.4.2.3 UK Market Status and Outlook (2013-2023)
1.4.2.4 Russia Market Status and Outlook (2013-2023)
1.4.2.5 Italy Market Status and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market Status and Outlook (2013-2023)
1.4.3.2 Japan Market Status and Outlook (2013-2023)
1.4.3.3 Korea Market Status and Outlook (2013-2023)
1.4.3.4 India Market Status and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market Status and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market Status and Outlook (2013-2023)
1.4.4.2 Egypt Market Status and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market Status and Outlook (2013-2023)
1.4.4.4 South Africa Market Status and Outlook (2013-2023)
1.4.4.5 Nigeria Market Status and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Oncolytic Virus Therapy Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Amgen Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Oncolytics Biotech
2.2.1 Business Overview
2.2.2 Oncolytic Virus Therapy Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Oncolytics Biotech Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Viralytics
2.3.1 Business Overview
2.3.2 Oncolytic Virus Therapy Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Viralytics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Transgene SA
2.4.1 Business Overview
2.4.2 Oncolytic Virus Therapy Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Transgene SA Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Oncolys BioPharma
2.5.1 Business Overview
2.5.2 Oncolytic Virus Therapy Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Oncolys BioPharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Targovax
2.6.1 Business Overview
2.6.2 Oncolytic Virus Therapy Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Targovax Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 PsiOxus Therapeutics
2.7.1 Business Overview
2.7.2 Oncolytic Virus Therapy Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 PsiOxus Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 SillaJen Biotherapeutics
2.8.1 Business Overview
2.8.2 Oncolytic Virus Therapy Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 SillaJen Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sorrento Therapeutics
2.9.1 Business Overview
2.9.2 Oncolytic Virus Therapy Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Sorrento Therapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Lokon Pharma
2.10.1 Business Overview
2.10.2 Oncolytic Virus Therapy Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Lokon Pharma Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Genelux Corporation
2.11.1 Business Overview
2.11.2 Oncolytic Virus Therapy Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Genelux Corporation Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Vyriad
2.12.1 Business Overview
2.12.2 Oncolytic Virus Therapy Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Vyriad Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 TILT Biotherapeutics
2.13.1 Business Overview
2.13.2 Oncolytic Virus Therapy Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 TILT Biotherapeutics Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Cold Genesys
2.14.1 Business Overview
2.14.2 Oncolytic Virus Therapy Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Cold Genesys Oncolytic Virus Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oncolytic Virus Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oncolytic Virus Therapy Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oncolytic Virus Therapy Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncolytic Virus Therapy Manufacturer Market Share
3.3.2 Top 6 Oncolytic Virus Therapy Manufacturer Market Share
3.4 Market Competition Trend
4 Global Oncolytic Virus Therapy Market Analysis by Regions
4.1 Global Oncolytic Virus Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Oncolytic Virus Therapy Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oncolytic Virus Therapy Revenue and Market Share by Regions (2013-2018)
4.2 North America Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
4.3 Europe Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
4.5 South America Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
5 North America Oncolytic Virus Therapy by Countries
5.1 North America Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
5.1.1 North America Oncolytic Virus Therapy Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oncolytic Virus Therapy Revenue and Market Share by Countries (2013-2018)
5.2 United States Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
5.3 Canada Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
5.4 Mexico Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6 Europe Oncolytic Virus Therapy by Countries
6.1 Europe Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
6.1.1 Europe Oncolytic Virus Therapy Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oncolytic Virus Therapy Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.3 UK Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.4 France Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.5 Russia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
6.6 Italy Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oncolytic Virus Therapy by Countries
7.1 Asia-Pacific Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oncolytic Virus Therapy Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oncolytic Virus Therapy Revenue and Market Share by Countries (2013-2018)
7.2 China Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.3 Japan Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.4 Korea Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.5 India Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
8 South America Oncolytic Virus Therapy by Countries
8.1 South America Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
8.1.1 South America Oncolytic Virus Therapy Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oncolytic Virus Therapy Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
8.3 Argentina Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
8.4 Colombia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oncolytic Virus Therapy by Countries
9.1 Middle East and Africa Oncolytic Virus Therapy Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oncolytic Virus Therapy Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oncolytic Virus Therapy Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.3 UAE Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.4 Egypt Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.5 Nigeria Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
9.6 South Africa Oncolytic Virus Therapy Sales and Growth Rate (2013-2018)
10 Global Oncolytic Virus Therapy Market Segment by Type
10.1 Global Oncolytic Virus Therapy Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oncolytic Virus Therapy Sales and Market Share by Type (2013-2018)
10.1.2 Global Oncolytic Virus Therapy Revenue and Market Share by Type (2013-2018)
11 Global Oncolytic Virus Therapy Market Segment by Application
11.1 Global Oncolytic Virus Therapy Sales Market Share by Application (2013-2018)
11.2 Melanoma Sales Growth (2013-2018)
11.3 Prostate Cancer Sales Growth (2013-2018)
11.4 Breast Cancer Sales Growth (2013-2018)
11.5 Ovarian Cancer Sales Growth (2013-2018)
11.6 Others Sales Growth (2013-2018)
12 Oncolytic Virus Therapy Market Forecast (2018-2023)
12.1 Global Oncolytic Virus Therapy Sales, Revenue and Growth Rate (2018-2023)
12.2 Oncolytic Virus Therapy Market Forecast by Regions (2018-2023)
12.2.1 North America Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.2 Europe Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.4 South America Oncolytic Virus Therapy Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oncolytic Virus Therapy Market Forecast (2018-2023)
12.3 Oncolytic Virus Therapy Market Forecast by Type (2018-2023)
12.3.1 Global Oncolytic Virus Therapy Sales Forecast by Type (2018-2023)
12.3.2 Global Oncolytic Virus Therapy Market Share Forecast by Type (2018-2023)
12.4 Oncolytic Virus Therapy Market Forecast by Application (2018-2023)
12.4.1 Global Oncolytic Virus Therapy Sales Forecast by Application (2018-2023)
12.4.2 Global Oncolytic Virus Therapy Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 24 hours.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 38154

Category: 11

Published date: 2018-03-25 14:19:33

Number of Pages: 108

Publisher Name: GIR

Over all Rating: 86 % (Average of Ratings provided by clients)